New York University (NYU) Langone Medical Center — New York, New York

New York University (NYU) Langone Medical Center is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

New York University (NYU) Langone Medical Center has participated in 8 clinical trials with 3 currently active.

Therapeutic areas: Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, Colorectal Cancer.

Sponsors: Eli Lilly and Company, Intercept Pharmaceuticals, Blueprint Medicines Corporation.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York University (NYU) Langone Medical Center?

New York University (NYU) Langone Medical Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York University (NYU) Langone Medical Center conducted?

New York University (NYU) Langone Medical Center has 8 clinical trials on record, with 3 currently active. Their work covers Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, Colorectal Cancer.

Is New York University (NYU) Langone Medical Center accredited by Crixeo Health?

Yes — New York University (NYU) Langone Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about New York University (NYU) Langone Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.